News

2 Beaten-Down Dividend Growth Stocks to Buy on the Dip
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
Obesity lab: India becomes ground zero for weight-loss drug race
India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expirations of blockbuster drugs. Pharmaceutical giants are ...
Should You Invest in This Under-the-Radar Weight Loss Stock?
Rhythm Pharmaceuticals' lone approved product currently generates minimal sales. If you're interested in capitalizing on the ...
2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Key Points Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks.Compass Pathways is developing psilocybin as a treatment for depression.Viking ...
Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...